Publicaciones en las que colabora con Oscar Briz Sánchez (28)

2020

  1. Role of genetic variations in the hepatic handling of drugs

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2019

  1. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

2018

  1. Chemoresistance and chemosensitization in cholangiocarcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453

  2. Genetic heterogeneity of SLC22 family of transporters in drug disposition

    Journal of Personalized Medicine, Vol. 8, Núm. 2

  3. Molecular bases of the poor response of liver cancer to chemotherapy

    Clinics and Research in Hepatology and Gastroenterology

2017

  1. Molecular bases of chemoresistance in cholangiocarcinoma

    Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900

2016

  1. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells

    Free Radical Biology and Medicine, Vol. 97, pp. 466-477

2014

  1. The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy

    Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10

2013

  1. Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets

    eLS

2012

  1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins

    Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576

2011

  1. A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225

2008

  1. Molecular bases of the fetal liver - Placenta - Maternal liver excretory pathway for cholephilic compounds

    Liver International, Vol. 28, Núm. 4, pp. 435-454

2007

  1. Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification

    Toxicology, Vol. 232, Núm. 1-2, pp. 24-36

  2. Cholestasis during pregnancy: Aetiopathogenesis, foetal-maternal repercussions and pharmacological treatments

    Current Women's Health Reviews, Vol. 3, Núm. 4, pp. 235-247

  3. Expression in Human Trophoblast and Choriocarcinoma Cell Lines, BeWo, Jeg-3 and JAr of Genes Involved in the Hepatobiliary-like Excretory Function of the Placenta

    Placenta, Vol. 28, Núm. 2-3, pp. 107-117

  4. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases

    Biochemical Pharmacology, Vol. 73, Núm. 9, pp. 1394-1404

2006

  1. Excretion of fetal biliverdin by the rat placenta-maternal liver tandem

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 290, Núm. 3

  2. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy

    Journal of Hepatology, Vol. 44, Núm. 6, pp. 1150-1157

2005

  1. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system

    Antiviral Research, Vol. 68, Núm. 2, pp. 75-83

  2. Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway.

    Annals of hepatology : official journal of the Mexican Association of Hepatology, Vol. 4, Núm. 2, pp. 70-76